Cyclacel Pharmaceuticals Inc (CYCC)
2.42
-0.42
(-14.79%)
USD |
NASDAQ |
May 15, 16:00
2.42
0.00 (0.00%)
After-Hours: 16:00
Cyclacel Pharmaceuticals Price: 2.42 for May 15, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 14, 2024 | 2.22 | 2.84 | 2.22 | 2.84 | 258727.0 |
May 13, 2024 | 2.46 | 2.720 | 2.370 | 2.54 | 387564.0 |
May 10, 2024 | 2.22 | 2.299 | 2.157 | 2.27 | 82157.00 |
May 09, 2024 | 2.35 | 2.60 | 2.271 | 2.31 | 204740.0 |
May 08, 2024 | 2.13 | 2.496 | 2.06 | 2.32 | 326504.0 |
May 07, 2024 | 2.07 | 2.180 | 2.020 | 2.11 | 248149.0 |
May 06, 2024 | 1.94 | 2.20 | 1.93 | 2.07 | 262797.0 |
May 03, 2024 | 2.37 | 2.52 | 1.935 | 2.00 | 566976.0 |
May 02, 2024 | 2.50 | 3.15 | 2.44 | 2.49 | 1.822M |
May 01, 2024 | 1.90 | 4.00 | 1.89 | 2.65 | 17.56M |
Apr 30, 2024 | 1.93 | 2.29 | 1.74 | 2.12 | 21.34M |
Apr 29, 2024 | 1.32 | 1.45 | 1.30 | 1.36 | 1.499M |
Apr 26, 2024 | 1.55 | 1.56 | 1.46 | 1.51 | 181642.0 |
Apr 25, 2024 | 1.78 | 1.987 | 1.41 | 1.60 | 3.490M |
Apr 24, 2024 | 1.86 | 2.350 | 1.85 | 2.300 | 551102.0 |
Apr 23, 2024 | 1.71 | 1.85 | 1.68 | 1.79 | 28374.00 |
Apr 22, 2024 | 1.80 | 1.93 | 1.73 | 1.75 | 25527.00 |
Apr 19, 2024 | 1.89 | 1.95 | 1.772 | 1.78 | 10391.00 |
Apr 18, 2024 | 1.91 | 1.96 | 1.81 | 1.85 | 37911.00 |
Apr 17, 2024 | 1.67 | 2.090 | 1.67 | 1.96 | 115080.0 |
Apr 16, 2024 | 1.52 | 1.72 | 1.52 | 1.67 | 48891.00 |
Apr 15, 2024 | 1.76 | 1.84 | 1.57 | 1.57 | 38778.00 |
Apr 12, 2024 | 1.91 | 1.91 | 1.76 | 1.76 | 29512.00 |
Apr 11, 2024 | 2.00 | 2.05 | 1.91 | 1.94 | 24158.00 |
Apr 10, 2024 | 2.09 | 2.11 | 1.95 | 2.05 | 38282.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.36
Minimum
Apr 29 2024
274.50
Maximum
Jan 10 2020
64.27
Average
53.70
Median
Nov 16 2020
Price Benchmarks
Corvus Pharmaceuticals Inc | 2.225 |
Oragenics Inc | 1.65 |
Relmada Therapeutics Inc | 3.49 |
Alpine Immune Sciences Inc | 64.97 |
MAIA Biotechnology Inc | 2.88 |
Price Related Metrics
Price to Book Value | 5.256 |
Earnings Yield | -1.12K% |
Market Cap | 3.190M |